stock.name

Vericel Corp

VCEL

Market Cap$2.31B
Close$

Compare Vericel

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Vericel CorpVericel Corp5130.70%0%12.1-
marketMarket Avg53.21.27%29%-1.3
HealthcareHealthcare Avg29.71.32%16%7.31.3
$51.00

Target Price by Analysts

5.5% upsideVericel Target Price DetailsTarget Price
$3.57

Current Fair Value

92.6% downside

Overvalued by 92.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.31 Billion
Enterprise Value$2.20 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.01
Beta1.24
Outstanding Shares48,601,736
Avg 30 Day Volume367,697

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio5130.66
PEG-10584.73
Price to Sales12.09
Price to Book Ratio12.09
Enterprise Value to Revenue10.6
Enterprise Value to EBIT-587.38
Enterprise Value to Net Income4885
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Vericel Corp

CEO: Dominick Colangelo